Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $986.65, giving the company a market capitalization of 930.87B. It carries a P/E multiple of 34.84 and pays a dividend yield of 64.4%.
On 2026-05-06, Eli Lilly(LLY) stock traded between a low of $964.41 and a high of $992.67. Shares are currently priced at $986.65, which is +2.3% above the low and -0.6% below the high.
The Eli Lilly(LLY)'s current trading volume is 2.95M, compared to an average daily volume of 3.76M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
LLY News
FDA adverse event reports highlight a serious case of hepatic failure in a patient using Foundayo, Eli Lilly's new oral GLP-1 drug. Eli Lilly (NYSE:LLY) states...
Omvoh Shows Durable Disease Clearance Disease clearance was evaluated among patients who achieved clinical remission with Omvoh at one year in the LUCENT-2 main...
New long-term data from Eli Lilly (LLY) show patients with moderately to severely active ulcerative colitis, or UC, treated with Omvoh achieved durable disease...
Analyst ratings
85%
of 33 ratingsMore LLY News
Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125% By Thomas Richmond Published May 4, 4:50PM EDT Quick Read Morning Brew Daily hosts a...
Key Points Eli Lilly's GLP-1 drugs generated nearly $13 billion in revenue last quarter. The company still has tremendous opportunities in international marke...
Key Points Novo Nordisk's Wegovy pill has created another boom in the GLP-1 drug market. Eli Lilly recently introduced its Foundayo pill for weight loss, three...
RBC Capital notes that Eli Liily shares were down as much as 3% in pre-market trading amid reports of a single FAERS hepatic failure case reported for Foundayo,...
Biotech and Pharma Street Notes FDA Reports Liver Failure in Patient Taking Lilly’s Foundayo In this article LLY SPX NVO Eli Lilly’s weight-loss pill, Foundayo,...
Eli Lilly (LLY) stock toppled Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure, according to a Food and Drug Administ...
The analyst who called NVIDIA in 2010 just named his top 10 stocks and Eli Lilly wasn't one of them. Get them here FREE . Lilly sits at the center of the GLP-1...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.